Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000244651 | SCV000318895 | likely benign | Cardiovascular phenotype | 2013-10-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV000500853 | SCV000597679 | uncertain significance | not specified | 2016-09-23 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000500853 | SCV000712584 | likely benign | not specified | 2016-10-25 | criteria provided, single submitter | clinical testing | p.Pro68Pro in exon 3 of TTN: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 6/66698 of European c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs201089861). |
Eurofins Ntd Llc |
RCV000732241 | SCV000860165 | uncertain significance | not provided | 2018-03-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080260 | SCV001009105 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000732241 | SCV001153214 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Gene |
RCV000732241 | SCV001866397 | likely benign | not provided | 2020-07-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000732241 | SCV003819833 | uncertain significance | not provided | 2019-08-14 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486795 | SCV004239852 | likely benign | Cardiomyopathy | 2023-03-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920011 | SCV004733771 | likely benign | TTN-related condition | 2019-10-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |